Marc studied medicine and finances, practiced surgery and ran an association of renowned clinics. After his medical career, Marc specialized in biotechnology companies. Marc is a trusted partner of the Oncidium foundation since the beginning. He is well aware of the Radiotheranostics market and developments and is involved in the foundation’s operations and activities.

Given his expertise, diplomacy and long-term involvement in the Oncidium foundation, Marc was appointed Chairman of the A.B.